eLife · 9 October 2026 · From issue 49
A membrane-disruptive action of VBIT-4 challenges its role as a widely used VDAC1 oligomerization inhibitor
A common lab drug damages cell membranes instead of blocking the protein clumping it was believed to stop.
Varun Ravishankar, Luís Borges-Araújo et al.
Integrity screen: passed (3 checks) Checked 12 October 2026. Read the source
The plain-language reading of this paper is in the full issue, for subscribers.
Read the full issue